Functional analyses of SMN/SMNc gene expression: therapeutic implications in Spinal Muscular Atrophy.

被引:0
|
作者
Burlet, P [1 ]
Bertrandy, S [1 ]
Vial, E [1 ]
Viollet, L [1 ]
Munnich, A [1 ]
Lefebvre, S [1 ]
机构
[1] Hop Necker Enfants Malad, INSERM U393, Paris, France
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
1729
引用
收藏
页码:A308 / A308
页数:1
相关论文
共 50 条
  • [1] Therapeutic implications by upregulating SMN2 expression in spinal muscular atrophy.
    Burlet, P
    Bertrandy, S
    Vial, E
    Viollet, L
    Munnich, A
    Lefebvre, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 432 - 432
  • [2] The SMNc gene is differentially expressed in varying severity of spinal muscular atrophy.
    Gavrilov, DK
    Shi, XY
    Wang, CH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A334 - A334
  • [3] Upregulation of SMN2 gene expression by 4-phenylbutyrate: relevance for a therapeutic approach to spinal muscular atrophy.
    Tiziano, FD
    Andreassi, C
    Angelozzi, C
    Vitali, T
    De Vincenzi, E
    Boninsegna, A
    Villanova, M
    Neri, G
    Brahe, C
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 587 - 587
  • [4] Relatedness of SMN gene deletion and conversion with clinical presentation in spinal muscular atrophy.
    Haider, MZ
    Moosa, A
    Habib, Y
    Reynold, L
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 386 - 386
  • [5] The loss-of-function of a SMN frameshift mutation in Spinal Muscular Atrophy.
    Lefebvre, S
    Bertrandy, S
    Burlet, P
    Munnich, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A53 - A53
  • [6] Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients
    Brahe, C
    Vitali, T
    Tiziano, FD
    Angelozzi, C
    Pinto, AM
    Borgo, F
    Moscato, U
    Bertini, E
    Mercuri, E
    Neri, G
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2005, 13 (02) : 256 - 259
  • [7] Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients
    Christina Brahe
    Tiziana Vitali
    Francesco D Tiziano
    Carla Angelozzi
    Anna Maria Pinto
    Federica Borgo
    Umberto Moscato
    Enrico Bertini
    Eugenio Mercuri
    Giovanni Neri
    European Journal of Human Genetics, 2005, 13 : 256 - 259
  • [8] Therapeutic strategies for spinal muscular atrophy: SMN and beyond
    Bowerman, Melissa
    Becker, Catherina G.
    Yanez-Munoz, Rafael J.
    Ning, Ke
    Wood, Matthew J. A.
    Gillingwater, Thomas H.
    Talbot, Kevin
    DISEASE MODELS & MECHANISMS, 2017, 10 (08) : 943 - 954
  • [9] Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy
    Aslesh, Tejal
    Yokota, Toshifumi
    CELLS, 2022, 11 (03)
  • [10] Reliability of Spinal Muscular Atrophy Functional Rating Scale (SMAFRS) in Ambulatory Adults with Spinal Muscular Atrophy.
    Elsheikh, Bakri
    King, Wendy
    Arnold, William
    Kissel, John
    NEUROLOGY, 2018, 90